Literature DB >> 35908271

Attrition from Care Among Men Initiating ART in Male-Only Clinics Compared with Men in General Primary Healthcare Clinics in Khayelitsha, South Africa: A Matched Propensity Score Analysis.

Tali Cassidy1,2,3, Morna Cornell4, Bubele Makeleni5, C Robert Horsburgh6,7,8, Laura Trivino Duran5, Virginia de Azevedo9, Andrew Boulle4,10, Matthew P Fox6,8,11.   

Abstract

Men have higher rates of attrition from antiretroviral therapy (ART) programs than women. In Khayelitsha, a high HIV prevalence area in South Africa, two public sector primary healthcare clinics offer services, including HIV testing and treatment, exclusively to men. We compared attrition from ART care among men initiating ART at these clinics with male attrition in six general primary healthcare clinics in Khayelitsha. We described baseline characteristics of patients initiating ART at the male and general clinics from 1 January 2014 to 31 March 2018. We used exposure propensity scores (generated based on baseline health and age) to match male clinic patients 1:1 to males at other clinics. The association between attrition (death or loss to follow-up, defined as no visits for nine months) and clinic type was estimated using Cox proportional hazards regression. Follow-up time began at ART initiation and ended at attrition, clinic transfer, or dataset closure. Before matching, patients from male clinics (n = 784) were younger than males from general clinics (n = 2726), median age: 31.2 vs 35.5 years. Those initiating at male clinics had higher median CD4 counts at ART initiation [Male Clinic 1: 329 (IQR 210-431), Male Clinic 2: 364 (IQR 260-536), general clinics 258 (IQR 145-398), cells/mm3]. In the matched analysis (1451 person-years, 1568 patients) patients initiating ART at male clinics had lower attrition (HR 0.71; 95% CI 0.60-0.85). In separate analyses for each of the two male clinics, only the more established male clinic showed a protective effect. Male-only clinics reached younger, healthier men, and had lower ART attrition than general services. These findings support clinic-specific adaptations to create more male-friendly environments.
© 2022. The Author(s).

Entities:  

Keywords:  Antiretroviral therapy; Differentiated service delivery; HIV; Males; Retention in care

Year:  2022        PMID: 35908271     DOI: 10.1007/s10461-022-03772-9

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  54 in total

1.  Public health blindness towards men in HIV programmes in Africa.

Authors:  Morna Cornell; Vivian Cox; Lynne Wilkinson
Journal:  Trop Med Int Health       Date:  2015-09-16       Impact factor: 2.622

2.  Men and antiretroviral therapy in Africa: our blind spot.

Authors:  Morna Cornell; James McIntyre; Landon Myer
Journal:  Trop Med Int Health       Date:  2011-03-21       Impact factor: 2.622

Review 3.  Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.

Authors:  Catrina Mugglin; Janne Estill; Gilles Wandeler; Nicole Bender; Matthias Egger; Thomas Gsponer; Olivia Keiser
Journal:  Trop Med Int Health       Date:  2012-09-20       Impact factor: 2.622

4.  Rates of HIV testing and diagnosis in South Africa: successes and challenges.

Authors:  Leigh F Johnson; Thomas M Rehle; Sean Jooste; Linda-Gail Bekker
Journal:  AIDS       Date:  2015-07-17       Impact factor: 4.177

5.  Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting.

Authors:  Claudia Hawkins; Guerino Chalamilla; James Okuma; Donna Spiegelman; Ellen Hertzmark; Eric Aris; Tarcila Ewald; Ferdinand Mugusi; Deo Mtasiwa; Wafaie Fawzi
Journal:  AIDS       Date:  2011-06-01       Impact factor: 4.177

6.  Life expectancy trends in adults on antiretroviral treatment in South Africa.

Authors:  Leigh F Johnson; Olivia Keiser; Matthew P Fox; Frank Tanser; Morna Cornell; Chris J Hoffmann; Hans Prozesky; Andrew Boulle; Mary-Ann Davies
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

Review 7.  Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis.

Authors:  Eric Druyts; Mark Dybul; Steve Kanters; Jean Nachega; Josephine Birungi; Nathan Ford; Kristian Thorlund; Joel Negin; Richard Lester; Sanni Yaya; Edward J Mills
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

8.  Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda.

Authors:  Edward J Mills; Celestin Bakanda; Josephine Birungi; Keith Chan; Robert S Hogg; Nathan Ford; Jean B Nachega; Curtis L Cooper
Journal:  J Int AIDS Soc       Date:  2011-11-03       Impact factor: 5.396

9.  Improvements in the South African HIV care cascade: findings on 90-90-90 targets from successive population-representative surveys in North West Province.

Authors:  Sheri A Lippman; Alison M El Ayadi; Jessica S Grignon; Adrian Puren; Teri Liegler; W D Francois Venter; Mary J Ratlhagana; Jessica L Morris; Evasen Naidoo; Emily Agnew; Scott Barnhart; Starley B Shade
Journal:  J Int AIDS Soc       Date:  2019-06       Impact factor: 5.396

10.  Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.

Authors:  Leigh F Johnson; Joel Mossong; Rob E Dorrington; Michael Schomaker; Christopher J Hoffmann; Olivia Keiser; Matthew P Fox; Robin Wood; Hans Prozesky; Janet Giddy; Daniela Belen Garone; Morna Cornell; Matthias Egger; Andrew Boulle
Journal:  PLoS Med       Date:  2013-04-09       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.